Explore Stifel's bullish outlook on American tobacco stocks ahead of Q3 earnings. Get insights on Philip Morris & Altria ...
Clinical Evaluation - A pharmacokinetic (PK) study launched in June 2025 under Good Clinical Practice (GCP) is ongoing to benchmark NicStripâ„¢ nicotine absorption against combustible cigarettes. These ...